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During cancer progression, cells lose their original tissue
contacts, move through the extracellular matrix (ECM),
enter into the lymphatic and/or blood system, extravasate,
and ultimately form new tumors. Therefore, tumor cells
inevitably experience alterations in cell-cell and cell-ECM
adhesion and the transformation activities of tumor cells
are highly inﬂuenced by cell adhesion via adhesion receptors
such as cadherins, integrins, cell surface proteoglycans,
and tetraspanins. These adhesion receptors, together with
extracellular ligands in the tumor microenvironment, couple
theextracellularenvironmenttointracellularsignals,thereby
enhancing cancer cell migration, invasion, proliferation, and
survival. Therefore, knowledge of the role of cell adhesion in
cancer is key to understanding the development of cancer,
and such knowledge could potentially form the basis for
eﬀective approaches to cancer treatment. Therefore, in this
issue, we have invited several authors to address such issues.
T h es p e c i a li s s u ew i l lb ec o m p o s e do ft h r e ep a r t s .As e t
of four papers discuss regulatory mechanisms in the light of
interesting issues that have arisen recently, such as the role
of cell-ECM interactions in genetic mutations in tumors, as
well as the important roles of lipid rafts, turnover of focal
adhesions, and anoikis resistance in cancer cell adhesion and
migration. All of these characteristics have been shown to
be important in cancer cell adhesion, and recent ﬁndings
provide potential mechanisms of tumor cell interactions and
metastatic activities.
Another set of ﬁve papers of this special issue address
the molecular level regulatory role of cell adhesion molecules
such as integrins and the immunoglobulin super family and
adhesion-related regulatory molecules such as plakoglobin,
HIC-5, and prostaglandins. All of these molecules have
received considerable attention in cell adhesion research
and have distinct role(s) in diﬀerent aspects of cancer
progression, but all are important regulators of human
carcinogenesis through their capacity to regulate cancer cell
adhesion. However, because their roles in cancer cell adhe-
sion and metastasis are still under investigation, this special
issue addresses their functional signiﬁcance, particularly in
the context of cancer cell adhesion.
A set of two papers address the possibility of suppressing
tumorsbyregulatingcelladhesionstatususingECM-derived
functional peptides or a physiological regulator such as
heparin.Researchinthisareawillimprovetheunderstanding
of cancer progression and may provide the basis for a new
strategy for treating cancer.
Eok-Soo Oh
Motoharu Seiki
Martin Gotte
Jun Chung